Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01491334 · ClinicalTrials.gov registry record
Validation of Transvaginal Tactile Imaging
A clinical trial of Pelvic Organ Prolapse, sponsored by Artann Laboratories.
- Completed
- Registry status
- 158
- Enrollment target
- 2
- Study locations
NCT01491334 is a study of Pelvic Organ Prolapse that has completed, run by Artann Laboratories. The registered enrollment target is 158 participants, above the 141-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (12% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT01491334, a study of Pelvic Organ Prolapse, has completed, sponsored by Artann Laboratories.
- COMPLETED
- Registry status
- 158 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to validate safety and effectiveness in assessment of the female pelvic floor tissue, and, assess the ability of Vaginal Tactile Imager (VTI) to detect early prolapse conditions and characterize the outcome of reconstructive surgery.
Conditions Studied
Study Locations (2)
New Jersey
- Princeton Urogynecology - Princeton
Pennsylvania
- Institute of Female Pelvic Medicine and Reconstructive Surgery - Allentown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 158 participants |
| Start Date | 2011-12 |
| Est. Completion | 2013-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01491334
The ClinicalTrials.gov registry entry for NCT01491334 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 158 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 141-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (12% higher). The listed sponsor is Artann Laboratories, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pelvic Organ Prolapse appearing as the primary indexed condition, and to 0 interventions.
NCT01491334 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New Jersey, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01491334 about?
NCT01491334 is a clinical study titled "Validation of Transvaginal Tactile Imaging". The purpose of this study is to validate safety and effectiveness in assessment of the female pelvic floor tissue, and, assess the ability of Vaginal Tactile Imager (VTI) to detect early prolapse conditions and characterize the outcome of reconstructive surgery.
What is the current status of trial NCT01491334?
This trial is currently completed. The enrollment target is 158 participants. The study started on 2011-12. Estimated completion is 2013-11.
What conditions does trial NCT01491334 study?
This clinical trial studies the following conditions: Pelvic Organ Prolapse.
Who is sponsoring clinical trial NCT01491334?
This trial is sponsored by Artann Laboratories, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01491334 being conducted?
This trial has 2 study locations across New Jersey, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pelvic Organ Prolapse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Centered Surgery - Preoperative Counseling and Patient Satisfaction
RECRUITING
-
Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry
RECRUITING
-
Pessary Experience Study
RECRUITING
-
SORE Study: Sitz Baths After Urogynecologic Reconstruction
RECRUITING · NA
-
POMEGRANATE Trial: Comparing Reia Pessary Versus Standard of Care Pessary for Pelvic Organ Prolapse Treatment
RECRUITING · NA
-
Sequence of Midurethral Sling Placement During Robotic Sacrocolpopexy
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.